Inventor

DANG QUN

US51 patents

⚠️ This page may combine multiple inventors who share the name “DANG QUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANG QUN

METABASIS THERAPEUTICS INC

Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphatase

Benzimidazole inhibitors of fructose 1,6-bisphosphatase

Purine inhibitors of fructose 1,6-bisphosphatase

Indole and azaindole inhibitors of fructose-1,6-bisphosphatase

Benzimidazole inhibitors of fructose 1,6-bisphosphatase

Indole and azaindole inhibitors of Fructose-1,6-biphosphatase

Purine inhibitors of fructose-1,6-bisphosphatase

Phenyl Phosphonate Fructose-1,6-Bisphosphatase Inhibitors

Antagonists of the glucagon receptor

Antagonists of the glucagon receptor

Heteroaromatic inhibitors of fructose 1,6-bisphosphatase

Antagonists of the glucagon receptor

Glucagon antagonists

Glucagon antagonists

Aryl fructose-1,6-bisphosphatase inhibitors

Purine inhibitors of fructose-1,6-bisphosphatase

Glucagon antagonists

Antagonists of the glucagon receptor

Activators of glucokinase

Activators of glucokinase

MERCK SHARP & DOHME

Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases

2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

Antidiabetic tricyclic compounds

Antidiabetic substituted heteroaryl compounds

Substituted pyrimidines

Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

Nargenicin compounds and uses thereof as antibacterial agents

Nargenicin compounds and uses thereof as antibacterial agents

Substituted pyrimidines

2′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

Indole derivatives useful as anti-diabetic agents

Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C

Hydroxy isoxazole compounds useful as GPR120 agonists

Antidiabetic tricyclic compounds

GIRIJAVALLABHAN VINAY

2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases

GOMEZ-GALENO JORGE E

Glucagon antagonists

Antagonists of the glucagon receptor

MCCOMAS CASEY C

Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases

Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases

HE SHUWEN

Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C

DESCHENES DENIS

Bipyridylaminopyridines as Syk inhibitors

TIAN FENG

Activators of glucokinase

VERMA VISHAL A

5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

BOOKSER BRETT C

Cyclic benzimidazole derivatives useful as anti-diabetic agents

BAO JIANMING

Cyclic benzimidazole derivatives useful as anti-diabetic agents

DANG QUN

Cyclic benzimidazole derivatives useful as anti-diabetic agents

ALECTOS THERAPEUTICS INC

Glycosidase inhibitors and uses thereof

ZHOU CHANGYOU

Substituted pyrimidines